Core Viewpoint - ST Yifei's stock price experienced a significant drop after resuming trading, attributed to internal control issues highlighted in the audit report by Lixin Accounting Firm, which raised concerns about the company's financial management and related party transactions [1][2]. Financial Performance - For the year 2024, ST Yifei reported revenue of 692 million yuan, a year-on-year decline of 0.74%, and a net profit of 24 million yuan, down 75.94% year-on-year. The net profit after deducting non-recurring items was 9.41 million yuan, a decrease of 87.57% [2]. - In the first quarter of 2025, the company achieved revenue of 236 million yuan, a year-on-year increase of 97.61%, while the net profit attributable to shareholders was 9.08 million yuan, down 42.7% [2]. Internal Control Issues - The audit report indicated significant deficiencies in ST Yifei's internal controls related to fundraising management and revenue recognition, leading to a negative opinion on the company's internal controls for the year 2024 [2][3]. - The company has initiated a comprehensive self-inspection and rectification process, revising and optimizing its fundraising management, internal audit, and financial reporting management systems [2]. Market Position and Future Outlook - ST Yifei has launched several new products in the new energy battery equipment sector, including high-speed assembly lines for square batteries and high-speed magnetic suspension cylindrical battery assembly lines [3]. - The company aims to strengthen its position in cylindrical all-tab battery equipment and expand into emerging fields such as solid-state batteries and sodium-ion batteries, while also improving internal controls and corporate governance [3].

Core Viewpoint - Jiangsu Shenneng Electric Power Co., Ltd. plans to conclude the "Production Expansion and Reconstruction Project of Sealing Components for Power Transmission and Transformation Equipment" and transfer the remaining raised funds to the "Reconstruction Project of Composite External Insulation Products for Power Transmission and Transformation" [2][9] Fundraising Overview - The company raised a total of approximately RMB 424 million through a non-public offering of 32,218,837 shares at a price of RMB 13.16 per share, with a net amount of approximately RMB 418 million after deducting related issuance costs [2][3] - The remaining raised funds amount to RMB 20.54 million, which will be transferred to the new project [2][7] Project Status - The first phase of the sealing components project had a planned total investment of RMB 162.19 million, with RMB 40.50 million allocated from the raised funds [4][6] - As of April 30, 2025, the first phase of the project has been completed and is ready for conclusion, while the second phase will continue to be implemented [6][9] Reasons for Fund Surplus - The surplus in raised funds is attributed to effective cost control and resource optimization during the project implementation, leading to reduced overall construction costs [6][7] - The company also achieved some financial returns from cash management of temporarily idle raised funds [6][7] Board and Supervisory Opinions - The board of directors and the supervisory board both agree that the decision to conclude the project and reallocate the surplus funds is prudent and will not adversely affect the company's operations or shareholder interests [10][11] Regulatory Compliance - The company has followed necessary procedures for the decision-making process, and the actions taken are in compliance with relevant regulations regarding the management and use of raised funds [12][13]

登录新浪财经APP 搜索【信披】查看更多考评等级 本议案尚需提交公司股东大会审议通过。 八、审议了江苏吴中医药发展股份有限公司关于终止实施第一期员工持股计划并注销相关股份的议案 因涉及全体监事自身利益，全体监事对本议案回避表决，本议案直接提交公司2024年度股东大会审议。 九、审议通过了江苏吴中医药发展股份有限公司关于终止实施2021年限制性股票激励计划暨回购注销相 关限制性股票的议案 监事会对本次终止实施2021年限制性股票激励计划并回购注销相关限制性股票事项进行了核实，认为： 本次终止实施2021年限制性股票激励计划暨回购注销相关限制性股票事项，符合《上市公司股权激励管 理办法》等相关法律法规、规范性文件以及公司《2021年限制性股票激励计划（草案）》的相关规定， 本次限制性股票回购数量、回购价格的审议程序符合相关规定，不存在损害公司及全体股东利益的情 形，不会对公司的财务状况和经营成果产生实质性影响。我们同意终止实施2021年限制性股票激励计划 暨回购注销相关限制性股票事项。 表决结果：3票同意， 0票弃权， 0票反对。 本议案尚需提交公司股东大会审议通过。 十、审议通过了江苏吴中医药发展股份有限公司监 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 以上生产经营数据，来自公司内部统计，仅为投资者及时了解公司生产经营概况之用，未对公司未来经 营情况做出任何明示或默示的预测或保证，敬请广大投资者理性投资，注意投资风险。 特此公告。 苏州赛伍应用技术股份有限公司董事会 2025年4月30日 证券代码：603212 证券简称：赛伍技术 公告编号：2025-020 苏州赛伍应用技术股份有限公司 关于召开2024年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 会议问题征集：投资者可于2025年05月15日前访问网址 https://eseb.cn/1nRH70vwnqE或使用微信扫描 下方小程序码进行会前提问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍关注的 问题进行回答。 ■ 二、说明会召开的时间、地点 （一）会议召开时间：2025年05月15日(星期四)下午16:00-17:00 （二）会议召开地点：价值在线（www.ir-online.cn） （三）会议召开方式：网络互动 ...

本公司于2024年8月30日召开第一届董事会第十七次会议、第一届董事会审计委员会第九次会议及第一 届监事会第十次会议，审议通过了《关于上海小方制药股份有限公司使用募集资金置换预先投入募投项 目及已支付发行费用的自筹资金的议案》，同意使用募集资金置换预先投入募投项目及已支付发行费用 的自筹资金，金额合计为人民币248,240,935.69元。截至2024年12月31日，本公司已完成募集资金置 换。 本公司2024年度募集资金实际使用情况详见附表1：《募集资金使用情况对照表》。 （二）募投项目先期投入及置换情况。 登录新浪财经APP 搜索【信披】查看更多考评等级 注2：2024年1月15日，本公司与保荐机构国信证券股份有限公司以及中国工商银行股份有限公司上海市 浦东分行签订了《募集资金三方监管协议》。因工商银行陆家嘴支行为下属分支机构，无签署《募集资 金三方监管协议》权限，故由其上级分行中国工商银行股份有限公司上海市浦东分行与本公司及保荐机 构国信证券股份有限公司签署《募集资金三方监管协议》。 注3：2024年1月16日，本公司与保荐机构国信证券股份有限公司以及上海浦东发展银行股份有限公司陆 家嘴支行签订了《募集 ...

Group 1 - The company is changing its accounting policies in accordance with the Ministry of Finance's new guidelines, specifically the "Interpretation No. 17" and "Interpretation No. 18" of the Enterprise Accounting Standards, effective from January 1, 2024 [3][4][6] - The board of directors and the supervisory board have approved the accounting policy changes, which do not require shareholder meeting approval [3][9][11] - The changes will not significantly impact the company's financial status or operating results, and they are designed to better reflect the company's financial condition and performance [9][10][12] Group 2 - The company has reported that it will implement the new accounting policies starting in 2024, adjusting comparative period information as necessary [6][8] - The previous accounting policies were based on the basic principles and specific accounting standards issued by the Ministry of Finance [7] - The new policies will enhance the accuracy and fairness of the company's financial reporting [10][11] Group 3 - The company is entering into a financial services agreement with China Gold Group Finance Co., Ltd., which is aimed at optimizing financial management and reducing financing costs [90][91] - The agreement will allow the company and its subsidiaries to access various financial services, including deposit and loan services, with a maximum daily deposit balance of RMB 13 billion [92][98] - The expected interest income from deposits and interest expenses from loans for 2025 are estimated at RMB 0.58 billion and RMB 0.20 billion, respectively [93]

Group 1 - The company needs to recognize a total credit impairment loss of RMB 53.02 million for the year 2024, based on assessments of expected credit losses for financial instruments [1] - The total asset impairment loss to be recognized for 2024 is RMB 23.77 million, with details provided in the financial statements [2] - The total impact of these impairment provisions will reduce the company's consolidated profit for 2024 by RMB 76.80 million [3] Group 2 - The company reported a net loss attributable to the parent company of RMB 157.16 million for 2024, resulting in cumulative undistributed losses of RMB 916.38 million as of December 31, 2024 [6] - The board has proposed not to distribute profits for 2024, which includes no cash dividends, no bonus shares, and no capital reserve conversion [5][9] - The profit distribution plan has been approved by the board and will be submitted for shareholder approval [7][10] Group 3 - The company has effectively managed its fundraising, with a total of RMB 721.89 million raised from its initial public offering, after deducting issuance costs [59] - As of December 31, 2024, the company has utilized RMB 101.41 million of the raised funds, with a total of RMB 547.00 million used cumulatively [15] - The company has established a clear management system for the use of raised funds, ensuring compliance with relevant regulations [16] Group 4 - The company has authorized the temporary use of up to RMB 150 million of idle raised funds to supplement working capital, with a usage period not exceeding 12 months [58] - The company has engaged in cash management of idle funds, generating a net income of RMB 4.00 million from cash management activities [26] - The company has maintained compliance with regulations regarding the management and use of raised funds, with no violations reported [33][34]

Fund Utilization - As of December 31, 2024, the company has four fundraising special accounts, with specific details on the actual use of raised funds available in the attached report [1] - The company has not used idle raised funds to temporarily supplement working capital as of December 31, 2024 [1] - The company approved the use of up to RMB 120 million of temporarily idle raised funds for cash management, investing in low-risk, high-liquidity products [1] Project Adjustments - The company has made adjustments to the implementation methods and locations of three fundraising projects due to ongoing challenges in land construction and the need for time to complete digital production workshops [3][4] - The total investment amounts for the projects have been reduced, with specific adjustments detailed for each project [3] Surplus Fund Management - The company has permanently supplemented working capital with surplus funds from a completed project, amounting to RMB 8.938 million, while retaining special accounts until all pending payments are settled [2] Compliance and Reporting - The company has strictly adhered to relevant laws and regulations regarding the storage and use of raised funds, ensuring timely and accurate disclosures [6] - There are no violations in the management and use of raised funds as of December 31, 2024 [6] Profit Distribution - The company plans to distribute a cash dividend of RMB 1.10 per 10 shares, totaling approximately RMB 9.639 million, which represents 36.69% of the net profit attributable to shareholders for the year [81][82] - The profit distribution plan is subject to approval at the upcoming annual shareholders' meeting [83] Audit and Governance - The company has proposed to reappoint Tianjian Accounting Firm as the auditor for the 2025 fiscal year, with the decision pending shareholder approval [8][73] - The audit committee has evaluated the performance of the accounting firm, affirming its compliance and capability to conduct audits effectively [75]

Group 1 - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any false records or misleading statements [2][6] - The first quarter financial statements are not audited, and the company has provided key financial data and indicators [3][4] - The company will hold its 2024 annual general meeting on May 20, 2025, with a network voting system in place [7][8] Group 2 - The company has opened a special account for raised funds and signed a four-party supervision agreement regarding the management of these funds [26][27] - The company raised a total of RMB 1,790,524,700.00 from its initial public offering, with a net amount of RMB 1,713,926,258.08 after deducting issuance costs [28] - The new special account is designated for specific projects and cannot be used for other purposes, ensuring compliance with relevant regulations [30][31]

Group 1 - The company raised a total of RMB 638,858.20 million from the issuance of 21,303,795 shares at a price of RMB 299.88 per share, with a net amount of RMB 614,562.26 million after deducting issuance costs [1][2] - As of December 31, 2024, the company has used RMB 566,529.30 million of the raised funds, leaving RMB 55,203.33 million unutilized, which includes RMB 44,703.33 million in a special account and RMB 10,500.00 million in cash management [2][6] - The company has established a management system for the raised funds, ensuring compliance with relevant laws and regulations, and has set up special accounts for fund storage [3][4] Group 2 - The company has not used idle raised funds to temporarily supplement working capital during the reporting period [8] - The company approved the use of up to RMB 100,000.00 million of temporarily idle raised funds for cash management, with a subsequent approval for RMB 50,000.00 million for safe and liquid cash management products [9][10] - The company has permanently supplemented working capital with RMB 141,000.00 million of over-raised funds, which was approved by the board and shareholders [12][13] Group 3 - The company reported a net profit of RMB -870,370,890.86 for 2024, leading to a proposal not to distribute profits or capital reserves [26][28] - The company has not triggered any risk warning situations as per the stock exchange rules despite the negative profit [28][29] - The company plans to establish a long-term, stable, and sustainable shareholder return mechanism [30] Group 4 - The company has not changed the investment projects funded by the raised funds, nor has it transferred or replaced any projects [16][17] - The company has complied with all regulations regarding the use and disclosure of raised funds, with no violations reported [18][21] - The company’s auditor confirmed that the management's report on the use of raised funds aligns with regulatory requirements and accurately reflects the situation [20][21]